newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Announces Bahrain Temporary License of Endari®

TORRANCE, Calif., Aug. 17, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that on August 12, 2021, the National Health Regulato